Trademark Overview
On Wednesday, December 13, 2006, a trademark application was filed for TAYORIZ with the United States Patent and Trademark Office. The USPTO has given the TAYORIZ trademark a serial number of 77062993. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, March 27, 2007. This trademark is owned by Glaxo Group Limited. The TAYORIZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines